Aldosterone-Producing Adenomas: Histopathology-Genotype Correlation and Identification of a Novel CACNA1D Mutation
Language English Country United States Media print-electronic
Document type Journal Article
Grant support
P 27809
Austrian Science Fund FWF - Austria
PubMed
28584016
DOI
10.1161/hypertensionaha.117.09057
PII: HYPERTENSIONAHA.117.09057
Knihovny.cz E-resources
- Keywords
- adrenal, aldosterone, primary hyperaldosteronism, zona fasciculata, zona glomerulosa,
- MeSH
- Adenoma * genetics pathology MeSH
- Aldosterone metabolism MeSH
- Adult MeSH
- G Protein-Coupled Inwardly-Rectifying Potassium Channels genetics MeSH
- Genetic Predisposition to Disease MeSH
- Hyperaldosteronism * genetics pathology MeSH
- Middle Aged MeSH
- Humans MeSH
- Adrenal Glands pathology MeSH
- Adrenal Gland Neoplasms * genetics pathology MeSH
- Sodium-Potassium-Exchanging ATPase genetics MeSH
- Calcium Channels, L-Type genetics MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Aldosterone MeSH
- ATP1A1 protein, human MeSH Browser
- CACNA1D protein, human MeSH Browser
- G Protein-Coupled Inwardly-Rectifying Potassium Channels MeSH
- KCNJ5 protein, human MeSH Browser
- Sodium-Potassium-Exchanging ATPase MeSH
- Calcium Channels, L-Type MeSH
Mutations in KCNJ5, ATP1A1, ATP2B3, CACNA1D, and CTNNB1 are thought to cause the excessive autonomous aldosterone secretion of aldosterone-producing adenomas (APAs). The histopathology of KCNJ5 mutant APAs, the most common and largest, has been thoroughly investigated and shown to have a zona fasciculata-like composition. This study aims to characterize the histopathologic spectrum of the other genotypes and document the proliferation rate of the different sized APAs. Adrenals from 39 primary aldosteronism patients were immunohistochemically stained for CYP11B2 to confirm diagnosis of an APA. Twenty-eight adenomas had sufficient material for further analysis and were target sequenced at hot spots in the 5 causal genes. Ten adenomas had a KCNJ5 mutation (35.7%), 7 adenomas had an ATP1A1 mutation (25%), and 4 adenomas had a CACNA1D mutation (14.3%). One novel mutation in exon 28 of CACNA1D (V1153G) was identified. The mutation caused a hyperpolarizing shift of the voltage-dependent activation and inactivation and slowed the channel's inactivation kinetics. Immunohistochemical stainings of CYP17A1 as a zona fasciculata cell marker and Ki67 as a proliferation marker were used. KCNJ5 mutant adenomas showed a strong expression of CYP17A1, whereas ATP1A1/CACNA1D mutant adenomas had a predominantly negative expression (P value =1.20×10-4). ATP1A1/CACNA1D mutant adenomas had twice the nuclei with intense staining of Ki67 than KCNJ5 mutant adenomas (0.7% [0.5%-1.9%] versus 0.4% [0.3%-0.7%]; P value =0.04). Further, 3 adenomas with either an ATP1A1 mutation or a CACNA1D mutation had >30% nuclei with moderate Ki67 staining. In summary, similar to KCNJ5 mutant APAs, ATP1A1 and CACNA1D mutant adenomas have a seemingly specific histopathologic phenotype.
References provided by Crossref.org